Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
Clinical trial NCT04390152 · TERMINATED
Trial details
- NCT number
- NCT04390152
- Sponsor
- BioXcellerator
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2022-03-03
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.